The ONCOLOGY Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted to recommend additional data for a new Drug application for Cindillizumab
San Francisco, USA and Suzhou, China, February 11, 2022 / PRnewswire / — The U.S. Food and Drug Administration (FDA)…